User profiles for "author:PJ Koos van Dam"

Koos PJ van Dam

MD, Neurology, Amsterdam UMC
Verified email at amsterdamumc.nl
Cited by 524

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective …

L Boekel, F Hooijberg, EH Vogelzang, YR Besten… - RMD open, 2022 - rmdopen.bmj.com
Background Research on the disease severity of COVID-19 in patients with rheumatic
immune-mediated inflammatory diseases (IMIDs) has been inconclusive, and long-term …

Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

L Wieske, EW Stalman, PJK van Dam… - Annals of the …, 2023 - ard.bmj.com
Patients with immune-mediated inflammatory diseases (IMIDs) may have impaired initial
humoral responses after SARS-CoV-2 vaccination depending on the type of …